Index by Author

September 1999; 22 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abrahamian, H

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  2. Aguilera, E

    • Usefulness of ambulatory blood pressure monitoring in pregnant women with type 1 diabetes. Diabetes Care September 1999 22:1507-1511; doi:10.2337/diacare.22.9.1507

  3. Aizawa, T

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

  4. Alibrandi, A

    • Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. Diabetes Care September 1999 22:1591-1592; doi:10.2337/diacare.22.9.1591

  5. Ambrosioni, E

    • ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care September 1999 22:1586-1587; doi:10.2337/diacare.22.9.1586

  6. Anderson, P J

    • Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care September 1999 22:1438-1444; doi:10.2337/diacare.22.9.1438

  7. Andrewes, D

    • Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care September 1999 22:1438-1444; doi:10.2337/diacare.22.9.1438

  8. Arcaro, G

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

B

  1. Babyak, L M

    • Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care September 1999 22:1549-1554; doi:10.2337/diacare.22.9.1549

  2. Bacchella, L

    • Leptin in children and adolescents with type 1 diabetes: a 2-year longitudinal study. Diabetes Care September 1999 22:1590-1591; doi:10.2337/diacare.22.9.1590a

  3. Bastyr, E J

    • Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care September 1999 22:1422-1427; doi:10.2337/diacare.22.9.1422

  4. Beerdsen, P

    • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care September 1999 22:1501-1506; doi:10.2337/diacare.22.9.1501

  5. Berg, T J

    • Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care September 1999 22:1543-1548; doi:10.2337/diacare.22.9.1543

  6. Bergeron, J

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  7. Bertoncello, N

    • Leptin in children and adolescents with type 1 diabetes: a 2-year longitudinal study. Diabetes Care September 1999 22:1590-1591; doi:10.2337/diacare.22.9.1590a

  8. Bienvenu, B

    • Sauna-induced diabetic ketoacidosis. Diabetes Care September 1999 22:1584; doi:10.2337/diacare.22.9.1584b

  9. Birkeland, K I

    • Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care September 1999 22:1543-1548; doi:10.2337/diacare.22.9.1543

  10. Bloomgarden, Z T

    • The European Association for the Study of Diabetes annual meeting, 1998: type 1 diabetes. Diabetes Care September 1999 22:1578-1583; doi:10.2337/diacare.22.9.1578

  11. Bonadonna, R C

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

  12. Bory, M

    • Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care September 1999 22:1396-1400; doi:10.2337/diacare.22.9.1396

  13. Bouchard, C

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  14. Boulton, A J

    • Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care September 1999 22:1428-1431; doi:10.2337/diacare.22.9.1428

  15. Bowsher, R R

    • Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care September 1999 22:1422-1427; doi:10.2337/diacare.22.9.1422

  16. Brancati, F L

    • Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care September 1999 22:1408-1414; doi:10.2337/diacare.22.9.1408

  17. Buithieu, M

    • Blood volumes and pain following capillary punctures in children and adolescents with diabetes. Diabetes Care September 1999 22:1592-1594; doi:10.2337/diacare.22.9.1592

  18. Bush, A J

    • Racial differences in the correlation between gonadal androgens and serum insulin levels. Diabetes Care September 1999 22:1524-1529; doi:10.2337/diacare.22.9.1524

C

  1. Campbell, L V

    • Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care September 1999 22:1401-1407; doi:10.2337/diacare.22.9.1401

  2. Caramori, M L

    • Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care September 1999 22:1512-1516; doi:10.2337/diacare.22.9.1512

  3. Castelnuovo, P

    • Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. Diabetes Care September 1999 22:1591-1592; doi:10.2337/diacare.22.9.1591

  4. Cerutti, F

    • Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care September 1999 22:1587-1588; doi:10.2337/diacare.22.9.1587

  5. Chan, J C

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  6. Chow, C C

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  7. Ciavarella, A

    • ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care September 1999 22:1586-1587; doi:10.2337/diacare.22.9.1586

  8. Clark, W S

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

  9. Cockram, C S

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  10. Cook, C B

    • Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care September 1999 22:1415-1421; doi:10.2337/diacare.22.9.1415
    • Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care September 1999 22:1494-1500; doi:10.2337/diacare.22.9.1494

  11. Couillard, C

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  12. Critchley, J A

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

D

  1. Dargis, V

    • Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care September 1999 22:1428-1431; doi:10.2337/diacare.22.9.1428

  2. Davidson, M B

    • Diabetes and disenrollment in a health maintenance organization setting: a 4-year longitudinal study with a matched cohort. Diabetes Care September 1999 22:1487-1489; doi:10.2337/diacare.22.9.1487

  3. Davies, J L

    • Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care September 1999 22:1479-1486; doi:10.2337/diacare.22.9.1479

  4. De Stefano, A M

    • Leptin in children and adolescents with type 1 diabetes: a 2-year longitudinal study. Diabetes Care September 1999 22:1590-1591; doi:10.2337/diacare.22.9.1590a

  5. DeFronzo, R A

    • Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care September 1999 22:1462-1470; doi:10.2337/diacare.22.9.1462

  6. Després, J P

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  7. Devarajoo, S

    • Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care September 1999 22:1597-1598; doi:10.2337/diacare.22.9.1597

  8. Du Pasquier-Fediaevsky, L

    • Discordance between physician and adolescent assessments of adherence to treatment: influence of HbA1c level. The PEDIAB Collaborative Group. Diabetes Care September 1999 22:1445-1449; doi:10.2337/diacare.22.9.1445

  9. Dunbar, V G

    • Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care September 1999 22:1415-1421; doi:10.2337/diacare.22.9.1415
    • Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care September 1999 22:1494-1500; doi:10.2337/diacare.22.9.1494

  10. Dyck, P J

    • Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care September 1999 22:1479-1486; doi:10.2337/diacare.22.9.1479

  11. d'Annunzio, G

    • Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. Diabetes Care September 1999 22:1591-1592; doi:10.2337/diacare.22.9.1591

  12. de Azevedo, M J

    • Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care September 1999 22:1512-1516; doi:10.2337/diacare.22.9.1512
    • Screening for diabetic nephropathy: is measurement of urinary albumin-to-creatinine ratio worthwhile? Diabetes Care September 1999 22:1599-1600; doi:10.2337/diacare.22.9.1599

E

  1. El-Kebbi, I M

    • Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care September 1999 22:1415-1421; doi:10.2337/diacare.22.9.1415
    • Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care September 1999 22:1494-1500; doi:10.2337/diacare.22.9.1494

  2. Endo, G

    • Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care September 1999 22:1432-1437; doi:10.2337/diacare.22.9.1432

  3. Ernst, K L

    • Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care September 1999 22:1494-1500; doi:10.2337/diacare.22.9.1494

  4. Esmatjes, E

    • Usefulness of ambulatory blood pressure monitoring in pregnant women with type 1 diabetes. Diabetes Care September 1999 22:1507-1511; doi:10.2337/diacare.22.9.1507

F

  1. Fiumi, N

    • ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care September 1999 22:1586-1587; doi:10.2337/diacare.22.9.1586

  2. Flores, L

    • Usefulness of ambulatory blood pressure monitoring in pregnant women with type 1 diabetes. Diabetes Care September 1999 22:1507-1511; doi:10.2337/diacare.22.9.1507

  3. Fujii, S

    • Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care September 1999 22:1432-1437; doi:10.2337/diacare.22.9.1432

  4. Funase, Y

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

G

  1. Gaillard, T

    • Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance. Diabetes Care September 1999 22:1588-1590; doi:10.2337/diacare.22.9.1588
    • Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients. Diabetes Care September 1999 22:1594-1596; doi:10.2337/diacare.22.9.1594

  2. Gallina, D L

    • Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care September 1999 22:1415-1421; doi:10.2337/diacare.22.9.1415
    • Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care September 1999 22:1494-1500; doi:10.2337/diacare.22.9.1494

  3. Gaur, L K

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

  4. Gay, V

    • Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care September 1999 22:1587-1588; doi:10.2337/diacare.22.9.1587

  5. Giorgini, A

    • Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care September 1999 22:1458-1461; doi:10.2337/diacare.22.9.1458

  6. Golden, S H

    • Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care September 1999 22:1408-1414; doi:10.2337/diacare.22.9.1408

  7. Gomis, R

    • Usefulness of ambulatory blood pressure monitoring in pregnant women with type 1 diabetes. Diabetes Care September 1999 22:1507-1511; doi:10.2337/diacare.22.9.1507

  8. Grabert, M

    • Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care September 1999 22:1555-1560; doi:10.2337/diacare.22.9.1555

  9. Gross, J L

    • Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care September 1999 22:1512-1516; doi:10.2337/diacare.22.9.1512
    • Screening for diabetic nephropathy: is measurement of urinary albumin-to-creatinine ratio worthwhile? Diabetes Care September 1999 22:1599-1600; doi:10.2337/diacare.22.9.1599

  10. Gutierrez, M

    • Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care September 1999 22:1422-1427; doi:10.2337/diacare.22.9.1422

H

  1. Habib, G

    • Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care September 1999 22:1396-1400; doi:10.2337/diacare.22.9.1396

  2. Hagopian, W A

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

  3. Hanssen, K F

    • Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care September 1999 22:1543-1548; doi:10.2337/diacare.22.9.1543

  4. Harvey, J N

    • Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care September 1999 22:1597-1598; doi:10.2337/diacare.22.9.1597

  5. Hashizume, K

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

  6. Hawa, M I

    • Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care September 1999 22:1458-1461; doi:10.2337/diacare.22.9.1458

  7. Hayashi, T

    • Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care September 1999 22:1432-1437; doi:10.2337/diacare.22.9.1432

  8. Hayward, C S

    • Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care September 1999 22:1401-1407; doi:10.2337/diacare.22.9.1401

  9. Heinze, E

    • Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care September 1999 22:1555-1560; doi:10.2337/diacare.22.9.1555

  10. Henry, R R

    • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care September 1999 22:1501-1506; doi:10.2337/diacare.22.9.1501

  11. Hermann, K M

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  12. Holl, R W

    • Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care September 1999 22:1555-1560; doi:10.2337/diacare.22.9.1555

  13. Hood, K

    • Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care September 1999 22:1597-1598; doi:10.2337/diacare.22.9.1597

  14. Hugo, K

    • Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care September 1999 22:1422-1427; doi:10.2337/diacare.22.9.1422

I

  1. Ilic, S

    • Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care September 1999 22:1422-1427; doi:10.2337/diacare.22.9.1422

  2. Imperatore, G

    • Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care September 1999 22:1490-1493; doi:10.2337/diacare.22.9.1490

  3. Imseis, R E

    • Racial differences in the correlation between gonadal androgens and serum insulin levels. Diabetes Care September 1999 22:1524-1529; doi:10.2337/diacare.22.9.1524

  4. Iovino, V

    • Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care September 1999 22:1490-1493; doi:10.2337/diacare.22.9.1490

  5. Irsigler, K

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  6. Irwin, L S

    • Diabetes in pregnancy and cesarean delivery. Diabetes Care September 1999 22:1561-1567; doi:10.2337/diacare.22.9.1561

  7. Isaacs, S D

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

  8. Iwamoto, Y

    • Pancreatic amyloid proteins and their relation to clinical diabetes, with special reference to serum insulin secretion. Diabetes Care September 1999 22:1590; doi:10.2337/diacare.22.9.1590b

J

  1. Janand-Delenne, B

    • Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care September 1999 22:1396-1400; doi:10.2337/diacare.22.9.1396

  2. Jonushaite, A

    • Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care September 1999 22:1428-1431; doi:10.2337/diacare.22.9.1428

  3. Jovanovic, L

    • Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care September 1999 22:1422-1427; doi:10.2337/diacare.22.9.1422

  4. Joyce, M

    • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care September 1999 22:1501-1506; doi:10.2337/diacare.22.9.1501

K

  1. Kaider, A

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  2. Kao, W H

    • Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care September 1999 22:1408-1414; doi:10.2337/diacare.22.9.1408

  3. Karibe, S

    • Pancreatic amyloid proteins and their relation to clinical diabetes, with special reference to serum insulin secretion. Diabetes Care September 1999 22:1590; doi:10.2337/diacare.22.9.1590b

  4. Katakura, M

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

  5. Kelly, R P

    • Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care September 1999 22:1401-1407; doi:10.2337/diacare.22.9.1401

  6. Kiener, H P

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  7. Kilhovd, B K

    • Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care September 1999 22:1543-1548; doi:10.2337/diacare.22.9.1543

  8. Kitabchi, A E

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517
    • Racial differences in the correlation between gonadal androgens and serum insulin levels. Diabetes Care September 1999 22:1524-1529; doi:10.2337/diacare.22.9.1524

  9. Ko, G T

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  10. Komatsu, M

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

L

  1. Lassmann-Vague, V

    • Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care September 1999 22:1396-1400; doi:10.2337/diacare.22.9.1396

  2. Lau, M S

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  3. Lechi, A

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

  4. Lee, Z S

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  5. Lefèbvre, P J

    • Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes. Diabetes Care September 1999 22:1568-1577; doi:10.2337/diacare.22.9.1568

  6. Legorreta, A P

    • Diabetes and disenrollment in a health maintenance organization setting: a 4-year longitudinal study with a matched cohort. Diabetes Care September 1999 22:1487-1489; doi:10.2337/diacare.22.9.1487

  7. Lemay, J F

    • Blood volumes and pain following capillary punctures in children and adolescents with diabetes. Diabetes Care September 1999 22:1592-1594; doi:10.2337/diacare.22.9.1592

  8. Lemieux, I

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  9. Lemieux, S

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  10. Leslie, R D

    • Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care September 1999 22:1458-1461; doi:10.2337/diacare.22.9.1458

  11. Leung, K M

    • Diabetes and disenrollment in a health maintenance organization setting: a 4-year longitudinal study with a matched cohort. Diabetes Care September 1999 22:1487-1489; doi:10.2337/diacare.22.9.1487

  12. Levy, I

    • Usefulness of ambulatory blood pressure monitoring in pregnant women with type 1 diabetes. Diabetes Care September 1999 22:1507-1511; doi:10.2337/diacare.22.9.1507

  13. Li, J K

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  14. Lin, A

    • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care September 1999 22:1501-1506; doi:10.2337/diacare.22.9.1501

  15. Lin, Z

    • Diabetes and disenrollment in a health maintenance organization setting: a 4-year longitudinal study with a matched cohort. Diabetes Care September 1999 22:1487-1489; doi:10.2337/diacare.22.9.1487

  16. Lindberg, F A

    • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care September 1999 22:1501-1506; doi:10.2337/diacare.22.9.1501

  17. Lorini, R

    • Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. Diabetes Care September 1999 22:1591-1592; doi:10.2337/diacare.22.9.1591

M

  1. Malini, P L

    • ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care September 1999 22:1586-1587; doi:10.2337/diacare.22.9.1586

  2. Martinez, S

    • Usefulness of ambulatory blood pressure monitoring in pregnant women with type 1 diabetes. Diabetes Care September 1999 22:1507-1511; doi:10.2337/diacare.22.9.1507

  3. Martini, A

    • Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. Diabetes Care September 1999 22:1591-1592; doi:10.2337/diacare.22.9.1591

  4. Matsuda, M

    • Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care September 1999 22:1462-1470; doi:10.2337/diacare.22.9.1462

  5. Mayer, G

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  6. McFarland, K F

    • Diabetes in pregnancy and cesarean delivery. Diabetes Care September 1999 22:1561-1567; doi:10.2337/diacare.22.9.1561

  7. McKeown, R E

    • Diabetes in pregnancy and cesarean delivery. Diabetes Care September 1999 22:1561-1567; doi:10.2337/diacare.22.9.1561

  8. McNitt, P M

    • Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care September 1999 22:1549-1554; doi:10.2337/diacare.22.9.1549

  9. Meadows, P A

    • Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care September 1999 22:1597-1598; doi:10.2337/diacare.22.9.1597

  10. Medici, F

    • Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care September 1999 22:1458-1461; doi:10.2337/diacare.22.9.1458

  11. Melton, L J

    • Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care September 1999 22:1479-1486; doi:10.2337/diacare.22.9.1479

  12. Meng, Y Y

    • Diabetes and disenrollment in a health maintenance organization setting: a 4-year longitudinal study with a matched cohort. Diabetes Care September 1999 22:1487-1489; doi:10.2337/diacare.22.9.1487

  13. Miller, D K

    • Serum fructosamine and obesity. Diabetes Care September 1999 22:1596-1597; doi:10.2337/diacare.22.9.1596

  14. Mixon, P S

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

  15. Monauni, T

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

  16. Morley, J E

    • Serum fructosamine and obesity. Diabetes Care September 1999 22:1596-1597; doi:10.2337/diacare.22.9.1596

  17. Mudaliar, S R

    • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care September 1999 22:1501-1506; doi:10.2337/diacare.22.9.1501

  18. Muggeo, M

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

  19. Mullen, P

    • Insulin lispro: the ideal pump insulin for patients with severe hypoglycemic unawareness? Diabetes Care September 1999 22:1598-1599; doi:10.2337/diacare.22.9.1598

N

  1. Nadeau, A

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  2. Naka, M

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

  3. Nakaya, F

    • Pancreatic amyloid proteins and their relation to clinical diabetes, with special reference to serum insulin secretion. Diabetes Care September 1999 22:1590; doi:10.2337/diacare.22.9.1590b

  4. Nepom, G T

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

  5. Nespoli, L

    • Leptin in children and adolescents with type 1 diabetes: a 2-year longitudinal study. Diabetes Care September 1999 22:1590-1591; doi:10.2337/diacare.22.9.1590a

  6. Nesto, R W

    • Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care September 1999 22:1393-1395; doi:10.2337/diacare.22.9.1393

  7. Northam, E A

    • Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care September 1999 22:1438-1444; doi:10.2337/diacare.22.9.1438

O

  1. O'Brien, P C

    • Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care September 1999 22:1479-1486; doi:10.2337/diacare.22.9.1479

  2. Okada, K

    • Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care September 1999 22:1432-1437; doi:10.2337/diacare.22.9.1432

  3. Oliveira, J

    • Screening for diabetic nephropathy: is measurement of urinary albumin-to-creatinine ratio worthwhile? Diabetes Care September 1999 22:1599-1600; doi:10.2337/diacare.22.9.1599

  4. Ooi, C

    • Insulin lispro: the ideal pump insulin for patients with severe hypoglycemic unawareness? Diabetes Care September 1999 22:1598-1599; doi:10.2337/diacare.22.9.1598

  5. Orsatti, C

    • Leptin in children and adolescents with type 1 diabetes: a 2-year longitudinal study. Diabetes Care September 1999 22:1590-1591; doi:10.2337/diacare.22.9.1590a

  6. Osei, K

    • Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance. Diabetes Care September 1999 22:1588-1590; doi:10.2337/diacare.22.9.1588
    • Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients. Diabetes Care September 1999 22:1594-1596; doi:10.2337/diacare.22.9.1594

P

  1. Pacaud, D

    • Blood volumes and pain following capillary punctures in children and adolescents with diabetes. Diabetes Care September 1999 22:1592-1594; doi:10.2337/diacare.22.9.1592

  2. Palmer, J P

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

  3. Palomba, E

    • Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care September 1999 22:1587-1588; doi:10.2337/diacare.22.9.1587

  4. Panelo, A

    • Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care September 1999 22:1458-1461; doi:10.2337/diacare.22.9.1458

  5. Pantelejeva, O

    • Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care September 1999 22:1428-1431; doi:10.2337/diacare.22.9.1428

  6. Pascot, A

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  7. Peart-Vigilance, C

    • Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care September 1999 22:1408-1414; doi:10.2337/diacare.22.9.1408

  8. Pecis, M

    • Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care September 1999 22:1512-1516; doi:10.2337/diacare.22.9.1512

  9. Peppard, H R

    • Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care September 1999 22:1549-1554; doi:10.2337/diacare.22.9.1549

  10. Perry, H M

    • Serum fructosamine and obesity. Diabetes Care September 1999 22:1596-1597; doi:10.2337/diacare.22.9.1596

  11. Pettitt, D J

    • Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care September 1999 22:1422-1427; doi:10.2337/diacare.22.9.1422

  12. Phillips, L S

    • Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care September 1999 22:1415-1421; doi:10.2337/diacare.22.9.1415
    • Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care September 1999 22:1494-1500; doi:10.2337/diacare.22.9.1494

  13. Piantanida, E

    • Leptin in children and adolescents with type 1 diabetes: a 2-year longitudinal study. Diabetes Care September 1999 22:1590-1591; doi:10.2337/diacare.22.9.1590a

  14. Platts, J K

    • Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care September 1999 22:1597-1598; doi:10.2337/diacare.22.9.1597

  15. Popp, G

    • Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care September 1999 22:1549-1554; doi:10.2337/diacare.22.9.1549

  16. Pourmotabbed, G

    • Racial differences in the correlation between gonadal androgens and serum insulin levels. Diabetes Care September 1999 22:1524-1529; doi:10.2337/diacare.22.9.1524

  17. Pozzilli, P

    • Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care September 1999 22:1458-1461; doi:10.2337/diacare.22.9.1458

  18. Prager, R

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  19. Prud'homme, D

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

R

  1. Rabensteiner, D

    • ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care September 1999 22:1530-1535; doi:10.2337/diacare.22.9.1530

  2. Ravelli, A

    • Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. Diabetes Care September 1999 22:1591-1592; doi:10.2337/diacare.22.9.1591

  3. Remsberg, K E

    • Diabetes in pregnancy and cesarean delivery. Diabetes Care September 1999 22:1561-1567; doi:10.2337/diacare.22.9.1561

  4. Riccardi, G

    • Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care September 1999 22:1490-1493; doi:10.2337/diacare.22.9.1490

  5. Rivellese, A A

    • Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care September 1999 22:1490-1493; doi:10.2337/diacare.22.9.1490

  6. Ruffa, G

    • Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care September 1999 22:1490-1493; doi:10.2337/diacare.22.9.1490

S

  1. Sacchetti, C

    • Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care September 1999 22:1587-1588; doi:10.2337/diacare.22.9.1587

  2. Saggiani, F

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

  3. Salvatoni, A

    • Leptin in children and adolescents with type 1 diabetes: a 2-year longitudinal study. Diabetes Care September 1999 22:1590-1591; doi:10.2337/diacare.22.9.1590a

  4. Samaras, K

    • Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care September 1999 22:1401-1407; doi:10.2337/diacare.22.9.1401

  5. Savin, B

    • Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care September 1999 22:1396-1400; doi:10.2337/diacare.22.9.1396

  6. Scheen, A J

    • Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes. Diabetes Care September 1999 22:1568-1577; doi:10.2337/diacare.22.9.1568

  7. Schuster, D P

    • Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance. Diabetes Care September 1999 22:1588-1590; doi:10.2337/diacare.22.9.1588
    • Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients. Diabetes Care September 1999 22:1594-1596; doi:10.2337/diacare.22.9.1594

  8. Service, F J

    • Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care September 1999 22:1479-1486; doi:10.2337/diacare.22.9.1479

  9. Solfelix, C M

    • Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients. Diabetes Care September 1999 22:1458-1461; doi:10.2337/diacare.22.9.1458

  10. Stansberry, K B

    • Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care September 1999 22:1549-1554; doi:10.2337/diacare.22.9.1549

  11. Strange, P

    • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care September 1999 22:1501-1506; doi:10.2337/diacare.22.9.1501

  12. Strocchi, E

    • ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care September 1999 22:1586-1587; doi:10.2337/diacare.22.9.1586

  13. Suematsu, C

    • Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care September 1999 22:1432-1437; doi:10.2337/diacare.22.9.1432

  14. Sullivan, D

    • Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care September 1999 22:1401-1407; doi:10.2337/diacare.22.9.1401

T

  1. Tasaka, Y

    • Pancreatic amyloid proteins and their relation to clinical diabetes, with special reference to serum insulin secretion. Diabetes Care September 1999 22:1590; doi:10.2337/diacare.22.9.1590b

  2. Tchernof, A

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  3. Thaler, L M

    • Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care September 1999 22:1415-1421; doi:10.2337/diacare.22.9.1415

  4. Thon, A

    • Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care September 1999 22:1555-1560; doi:10.2337/diacare.22.9.1555

  5. Thorsby, P

    • Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care September 1999 22:1543-1548; doi:10.2337/diacare.22.9.1543

  6. Timsit, J

    • Sauna-induced diabetic ketoacidosis. Diabetes Care September 1999 22:1584; doi:10.2337/diacare.22.9.1584b

  7. Tovo, P A

    • Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care September 1999 22:1587-1588; doi:10.2337/diacare.22.9.1587

  8. Tremblay, A

    • Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care September 1999 22:1471-1478; doi:10.2337/diacare.22.9.1471

  9. Tsumura, K

    • Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care September 1999 22:1432-1437; doi:10.2337/diacare.22.9.1432

  10. Tubiana-Rufi, N

    • Discordance between physician and adolescent assessments of adherence to treatment: influence of HbA1c level. The PEDIAB Collaborative Group. Diabetes Care September 1999 22:1445-1449; doi:10.2337/diacare.22.9.1445

U

  1. Umpierrez, G E

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

V

  1. Vaccaro, O

    • Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care September 1999 22:1490-1493; doi:10.2337/diacare.22.9.1490

  2. Vague, P

    • Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care September 1999 22:1396-1400; doi:10.2337/diacare.22.9.1396

  3. Versace, A

    • Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care September 1999 22:1587-1588; doi:10.2337/diacare.22.9.1587

  4. Vileikyte, L

    • Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care September 1999 22:1428-1431; doi:10.2337/diacare.22.9.1428

  5. Vinik, A I

    • Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care September 1999 22:1549-1554; doi:10.2337/diacare.22.9.1549

W

  1. Warne, G L

    • Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care September 1999 22:1438-1444; doi:10.2337/diacare.22.9.1438

  2. Werther, G A

    • Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care September 1999 22:1438-1444; doi:10.2337/diacare.22.9.1438

  3. Williams, G

    • Insulin lispro: the ideal pump insulin for patients with severe hypoglycemic unawareness? Diabetes Care September 1999 22:1598-1599; doi:10.2337/diacare.22.9.1598

  4. Williams-Cleaves, B

    • Racial differences in the correlation between gonadal androgens and serum insulin levels. Diabetes Care September 1999 22:1524-1529; doi:10.2337/diacare.22.9.1524

  5. Wilson, D M

    • Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care September 1999 22:1479-1486; doi:10.2337/diacare.22.9.1479

  6. Woo, W

    • Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care September 1999 22:1517-1523; doi:10.2337/diacare.22.9.1517

Y

  1. Yale, J F

    • Blood volumes and pain following capillary punctures in children and adolescents with diabetes. Diabetes Care September 1999 22:1592-1594; doi:10.2337/diacare.22.9.1592

  2. Yamauchi, K

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

  3. Yeung, V T

    • Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care September 1999 22:1450-1457; doi:10.2337/diacare.22.9.1450

  4. Yoshizawa, K

    • Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency. Diabetes Care September 1999 22:1584-1586; doi:10.2337/diacare.22.9.1584a

Z

  1. Zelmanovitz, T

    • Screening for diabetic nephropathy: is measurement of urinary albumin-to-creatinine ratio worthwhile? Diabetes Care September 1999 22:1599-1600; doi:10.2337/diacare.22.9.1599

  2. Zenere, B M

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

  3. Zenti, M G

    • ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care September 1999 22:1536-1542; doi:10.2337/diacare.22.9.1536

  4. Ziemer, D C

    • Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care September 1999 22:1415-1421; doi:10.2337/diacare.22.9.1415
    • Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care September 1999 22:1494-1500; doi:10.2337/diacare.22.9.1494

Current Issue

  1. March 2010, 33 (3)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care